Soft Cell Biological Research

May 14, 2021

Soft Cell Biological (Soft Cell) has developed a patent-pending protocol to culture and examine hidden bacteria in the circulatory system. The company’s ultimate goal is to reveal the link between these bacteria, autoimmune disorders, and recurrent infection. Preliminary testing reveals that donors suffering from chronic fatigue, fibromyalgia, arthritis, and anemia carry high concentrations of L-form bacteria in their blood. The ability to culture L-form bacteria from two drops of blood reveals new avenues toward solving these problems.